Publications

1. “Antihyperglycemic Effect of Dehydroepiandrosterone Analogue 16a-Fluoro-5-androsten-17-one in Diabetic Mice”, Schwartz et al, DIABETES, VOL. 42, 1993

2. “Novel Dehydroepiandrosterone Analogues with Enhanced Biological Activity and Reduced Side Effects in Mice and Rats”, Schwartz et al, Cancer research, 1988

3. “Topical Steroidal Formulations”, Schwartz et al. Patent No. US 8,431,555B2(2013)

4. “A Synthetic Androstene analogue inhibits collagen-induced arthritis in the mouse”, Halina et al, Clinical Immunology, 2003

5. “Suppression of 12-O-tetradecanoylphorbol-13-acetate-induced epidermal hyperplasia and in ammation by the dehydroepiandrosterone analog 16a-uoro-5-androsten-17-one and its reversal by NADPH liposomes”, Schwartz et al, Cancer Letters, 2001

6. Abstract “HE2500, A Stable Synthetic Derivative of DHEA, significantly reduces or eliminates lesions in a murine model of psoriasis”